Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Genetic Dilated Cardiomyopathy with Dr Nosheen Reza
Author(s): Nosheen Reza Added: 2 months ago
Explore the clinical approach to identifying and managing genetic dilated cardiomyopathy (DCM) with Dr Nosheen RezaThis presentation, part of the comprehensive Cardiomyopathies track, demonstrates how comprehensive family history assessment and systematic genetic evaluation can transform the diagnosis and management of patients presenting with dilated cardiomyopathy, revealing familial patterns… View more

CV Disease in Special Populations

Imaging & Diagnostics
Added: 2 weeks ago Source:  Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv… View more

Heart Failure

Imaging & Diagnostics
Percutaneous Retrieval Dislodged Port Catheter
Author(s): Dharmaraj Karthikesan , Mohd Ridzuan Mohd Said , Chin Yung Chea , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery
Novel Technique Retrieving a Fractured Guiding Catheter
Author(s): Jia Min Chua , Paul Jau Lueng Ong , Randal Jun Bang Low Added: 5 months ago

Intervention

MI/ACS
ECAS Guidelines on Catheter Ablation for Atrial Fibrillation
Author(s): Riccardo Cappato , Rui Providencia Added: 10 months ago
What updates do ECAS recommend for catheter ablation of atrial fibrillation?In this short interview, Prof Riccardo Cappato (IRCCS Humanitas Research Hospital, Milan, IT) and Prof Rui Providência (St Bartholomew's Hospital, London, UK) discuss new guidelines released by ECAS on catheter ablation for atrial fibrillation (AF). Prof Cappato and Prof Providência explain the need for an updated and… View more

Electrophysiology & Arrhythmia
HRS New Policy Statement for Catheter Ablation of AF
Author(s): Kenneth Ellenbogen Added: 1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best… View more

Electrophysiology & Arrhythmia
Predicting LVEF Improvement After AF Catheter Ablation
Author(s): Nikhil Ahluwalia , Ahmed Hussain , Rui Providencia , et al Added: 11 months ago

Electrophysiology & Arrhythmia

Heart Failure
EHRA 24: FIH Novel PFA Catheter for PVI
Author(s): Vivek Reddy Added: 1 year ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more

Electrophysiology & Arrhythmia
Catheter Ablation for Vasovagal Syncope
Author(s): Mohamed Zuhair , Daniel Keene , Dimitrios Panagopoulos , et al Added: 1 year ago

Electrophysiology & Arrhythmia
AF Symposium 25: LAAC Vs Oral Anticoagulation After Catheter Ablation
Author(s): Walid Saliba Added: 1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and… View more

Anticoagulation

Electrophysiology & Arrhythmia